Important: This guide is for educational purposes only and is not medical advice
Tirzepatide GI profile Tirzepatide as a dual GLP-1/GIP agonist produces GI side effects somewhere between semaglutide and retatrutide in both rate and severity
If youve successfully lost weight with GLP-1 medications but struggle with excess skin that diminishes your achievement, a tummy tuck might be your next step
Furthermore, the Outsourcing Facilities Association has sued the FDA, claiming the removal of semaglutide from the shortage list is arbitrary and capricious because there are still risks of supply shortages
Through these studies, researchers reported that over 72 weeks, participants who took the highest dose of Zepbound lost an average of 48 lbs, and those who took the lowest dose lost an average of 34 lbs
When patients lose significant weight using semaglutide or other GLP-1 medications, skin appearance often changessometimes improving, sometimes revealing new concerns like cellulite